World's Best Scientists 2026 revealed!
Award Badge
Medicine
Israel
2023

D-Index & Metrics

Medicine

D-Index
131
Citations
70320
World Ranking
2383
National Ranking
4

Raphael Mechoulam publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Raphael Mechoulam sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 510 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Raphael Mechoulam D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Raphael Mechoulam sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 131 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Israel Leader Award
  • 2022 - Research.com Medicine in Israel Leader Award

Overview

Raphael Mechoulam was affiliated with the Hebrew University of Jerusalem in Israel. Their research primarily focused on medicine, with extensive work in pharmacology, cellular and molecular neuroscience, molecular biology, physiology, and materials chemistry.

The scientist's main topics of research covered cannabis and cannabinoid research, neurotransmitter receptor influence on behavior, polyamine metabolism and applications, crystallization and solubility studies, X-ray diffraction in crystallography, diet and metabolism studies, and bipolar disorder and treatment.

Raphael Mechoulam published several recent papers, including:

  • Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic, 2021, JAMA Network Open
  • Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats, 2020, Pharmacological Research
  • Anti-Biofilm Activity of Cannabidiol against Candida albicans, 2021, Microorganisms
  • Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment, 2020, Biochemical Pharmacology
  • Adherence, Safety, and Effectiveness of Medical Cannabis and Epidemiological Characteristics of the Patient Population: A Prospective Study, 2022, Frontiers in Medicine

The frequent coauthors working alongside Mechoulam included Reem Smoum, Linda A. Parker, Vincenzo Di Marzo, Erin M. Rock, and Ruth Gallily.

Publications appeared most commonly in the following venues:

  • Cannabis and Cannabinoid Research
  • The Cambridge Structural Database
  • Molecules
  • Psychopharmacology
  • Frontiers in Pharmacology

Mechoulam also contributed to scholarly books, with a notable publication titled CBD released by The MIT Press in 2022.

Best Publications

  • ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR

    William A. Devane;Lumir Hanuš;Aviva Breuer;Roger G. Pertwee

  • International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

    A C Howlett;F Barth;T I Bonner;G Cabral

  • Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

    Raphael Mechoulam;Shimon Ben-Shabat;Lumir Hanus;Moshe Ligumsky

  • International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

    Roger Guy Pertwee;A. C. Howlett;M. E. Abood;S. P. H. Alexander

  • Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.

    Tiziana Bisogno;Lumír Hanuš;Luciano De Petrocellis;Susanna Tchilibon

  • The Endocannabinoid System and the Brain

    Raphael Mechoulam;Linda A. Parker

  • 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

    Lumír Hanuš;Saleh Abu-Lafi;Ester Fride;Aviva Breuer

  • Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

    Angelo A. Izzo;Francesca Borrelli;Raffaele Capasso;Vincenzo Di Marzo

  • An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

    David Panikashvili;Constantina Simeonidou;Shimon Ben-Shabat;Lumír Hanuš

  • The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

    A. M. Malfait;R. Gallily;P. F. Sumariwalla;A. S. Malik

  • Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients

    Jomar M. Cunha;E.A. Carlini;Aparecido E. Pereira;Oswaldo L. Ramos

  • An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity.

    Shimon Ben-Shabat;Ester Fride;Tzviel Sheskin;Tsippy Tamiri

  • HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor

    L. Hanuš;A. Breuer;S. Tchilibon;S. Shiloah

  • Endocannabinoid signaling at the periphery: 50 years after THC

    Mauro Maccarrone;Itai Bab;Tamás Bíró;Guy A. Cabral

  • Cannabidiol – Recent Advances

    Raphael Mechoulam;Maximilian Peters;Eric Murillo‐Rodriguez;Lumír O. Hanuš

  • Cannabidiol: an overview of some pharmacological aspects.

    Raphael Mechoulam;Linda A. Parker;Ruth Gallily

  • Peripheral cannabinoid receptor, CB2, regulates bone mass

    Orr Ofek;Meliha Karsak;Nathalie Leclerc;Meirav Fogel

  • Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent

    Ester Fride;Raphael Mechoulam

  • The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.

    P B Smith;D R Compton;S P Welch;R K Razdan

  • Is lipid signaling through cannabinoid 2 receptors part of a protective system

    P. Pacher;R. Mechoulam

Frequent Co-Authors

Esther Shohami
Esther Shohami Hebrew University of Jerusalem
Linda A. Parker
Linda A. Parker University of Guelph
Vincenzo Di Marzo
Vincenzo Di Marzo National Research Council (CNR)
Roger G. Pertwee
Roger G. Pertwee University of Aberdeen
Zvi Vogel
Zvi Vogel Weizmann Institute of Science
Filippo Drago
Filippo Drago University of Catania
Pal Pacher
Pal Pacher National Institutes of Health
Mauro Maccarrone
Mauro Maccarrone University of L'Aquila
Anat Biegon
Anat Biegon Stony Brook University
Javier Fernández-Ruiz
Javier Fernández-Ruiz Complutense University of Madrid

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens up a diverse range of online education and career options in healthcare. For those aiming to accelerate their nursing credentials, several programs offer flexible, accessible pathways to advanced roles.

Many registered nurses are now seeking doctorate-level qualifications through highly efficient online options. For example, a 1 year dnp program online is available for experienced nurses who want to fast-track their leadership and clinical expertise. Additionally, candidates looking for efficiency can explore the shortest dnp program available, minimizing the time needed to earn this prestigious degree.

Those at the early stages of their career may benefit from fast track lpn programs online, which offer a rapid route into practical nursing. For specialization, the fastest psych np program can open doors to specialized practice as a psychiatric mental health nurse practitioner.

Before deciding, prospective students should consider program accreditation, workload, and clinical requirements to ensure their chosen path aligns with their long-term goals.

Best Scientists Citing Raphael Mechoulam

Recently Published Articles